Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

The Medical City South Luzon (TMCSL) introduces MALDI-TOF Mass Spectrometry, becoming the first hospital in the region to ...

Until recently, clinical diagnostic laboratories predominantly relied on conventional phenotypic ways of diagnosing infections, and sometimes on gene sequencing techniques. The latest advancements in ...

Novel Method to Finding New Drug Candidates with Promising Therapeutic Applications Over the last few decades, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) has proven its ...

Boston-based PerkinElmer Life and Analytical Sciences has released the prOTOF™ 2000, the first commercially available matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass ...

Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on the innovation and evolution of the FDA-cleared MALDI Biotyper ® CA System.

It's been 20 years since Hillenkamp and Karas developed MALDI. In that time, the soft ionization method, coupled with time-of-flight (TOF) mass spectrometry, has distinguished itself as the enabling ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Fast and reliable identification of ...

MALDI imaging - an analytical technique that detects potential biomarkers directly from tissue sections - has become popular over the last 10 years. One significant aspect is the development protocols ...

Over the last few decades, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) has proven its usefulness and robustness in many applications. Recent innovations in MALDI-MS ...